ISRCTN50749194未知未知
The effect of a novel polysaccharide blend (PGX® micro-granules) on short- term weight loss and other laboratory parameters in overweight and obese adults: an observational retrospective analysis
Factors Group of Nutritional Companies Inc. (Canada)0 个研究点目标入组 29 人开始时间: 2007年10月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 29
研究概览
简要总结
Results article in https://pubmed.ncbi.nlm.nih.gov/20359270/ (added 19/07/2021)
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. 20 to 65 year of age
- •2. Body mass index range of approximately 23 kg/m^2 to 35 kg/m^2
- •3. Otherwise healthy
排除标准
- •1. Morbid obesity
- •2. Major psychiatric diagnosis
- •3. Use of other weight loss medications such as sibutramine or ephedra
研究者
相似试验
已完成
2 期
Reduction of the Glycemic Index by a Novel Viscous PolysaccharideBlood Glucose, PostprandialNCT00935350Glycemic Index Laboratories, Inc10
已完成
不适用
Effect of the intake of PGX, a novel soluble viscous polysaccharide complex, on Insulin / Cholesterol / Triglycerides and Blood Sugar levels as well as body mass change over 14 weeks in Japanese subjects. A randomised controlled study.JPRN-UMIN000009196TTC60
进行中（未招募）
4 期
TyVAC Bangladesh: Typhoid Vaccine TrialBlood culture confirmed typhoid feverInfections and InfestationsPrevention of typhoid fever (Salmonella typhi infection)ISRCTN11643110niversity of Oxford32,500
已完成
2 期
Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial GlycemiaBlood Glucose, PostprandialNCT00801814Glycemic Index Laboratories, Inc20
已完成
3 期
TyVAC Nepal: typhoid vaccine studyTyphoid feverISRCTN43385161niversity of Oxford20,019